These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 23794320)

  • 1. Adverse drug reactions in patients with Alzheimer's disease and related dementia in France: a national multicentre cross-sectional study.
    Laroche ML; Perault-Pochat MC; Ingrand I; Merle L; Kreft-Jais C; Castot-Villepelet A; Durrieu G; Gras V; Guy C; Jean-Pastor MJ; Jonville-Béra AP; Merlet-Chicoine I; Miremont-Salamé G; Nourhashemi F; Charmes JP;
    Pharmacoepidemiol Drug Saf; 2013 Sep; 22(9):952-60. PubMed ID: 23794320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence of hospital admissions due to adverse drug reactions in France: the EMIR study.
    Bénard-Laribière A; Miremont-Salamé G; Pérault-Pochat MC; Noize P; Haramburu F;
    Fundam Clin Pharmacol; 2015 Feb; 29(1):106-11. PubMed ID: 24990220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug interactions between antihypertensive drugs and non-steroidal anti-inflammatory agents: a descriptive study using the French Pharmacovigilance database.
    Fournier JP; Sommet A; Durrieu G; Poutrain JC; Lapeyre-Mestre M; Montastruc JL;
    Fundam Clin Pharmacol; 2014 Apr; 28(2):230-5. PubMed ID: 23190210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adverse drug reactions in patients older than 70 years during the heat wave occurred in France in summer 2003: A study from the French PharmacoVigilance Database.
    Michenot F; Sommet A; Bagheri H; Lapeyre-Mestre M; Montastruc JL;
    Pharmacoepidemiol Drug Saf; 2006 Oct; 15(10):735-40. PubMed ID: 16924603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Online reporting of adverse drug reactions: a study from a French regional pharmacovigilance center.
    Abadie D; Chebane L; Bert M; Durrieu G; Montastruc JL
    Therapie; 2014; 69(5):395-400. PubMed ID: 25269141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Serious Adverse Drug Reaction and Their Preventability in the Elderly Over 65 Years].
    Kanagaratnam L; Abou Taam M; Heng M; De Boissieu P; Roux MP; Trenque T
    Therapie; 2015; 70(5):477-84. PubMed ID: 26223243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adverse drug reactions in elderly subjects hospitalized in a specialized dementia management unit.
    Kanagaratnam L; Mahmoudi R; Novella JL; Jolly D; Dramé M; Trenque T
    Drugs Aging; 2014 Oct; 31(10):769-76. PubMed ID: 25200414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of drug treatments for Alzheimer's disease in France: a study on a national level based on the National Alzheimer's Data Bank (Banque Nationale Alzheimer).
    Tifratene K; Duff FL; Pradier C; Quetel J; Lafay P; Schück S; Benzenine E; Quantin C; Robert P
    Pharmacoepidemiol Drug Saf; 2012 Sep; 21(9):1005-12. PubMed ID: 22718684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of pharmacovigilance on adverse drug reactions reporting in hospitalized internal medicine patients at Saudi Arabian teaching hospital.
    Khan LM; Al-Harthi SE; Saadah OI; Al-Amoudi AB; Sulaiman MI; Ibrahim IM
    Saudi Med J; 2012 Aug; 33(8):863-8. PubMed ID: 22886119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Changes in drug management of Alzheimer's disease in nursing homes: Impact of the media campaign against specific drugs for Alzheimer's disease].
    Petit AE; Mangeard H; Chazard E; Puisieux F
    Encephale; 2017 Feb; 43(1):21-26. PubMed ID: 27039155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of dementia and Alzheimer's disease in elders of nursing homes and a senior center of Durango City, Mexico.
    Alvarado-Esquivel C; Hernández-Alvarado AB; Tapia-Rodríguez RO; Guerrero-Iturbe A; Rodríguez-Corral K; Martínez SE
    BMC Psychiatry; 2004 Feb; 4():3. PubMed ID: 15070420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antipsychotic prescribing for Alzheimer's disease and related disorders in specialized settings from 2010 to 2014 in France: a repeated cross-sectional study.
    Tifratene K; Manera V; Fabre R; Gros A; Thummler S; Pradier C; Robert P; David R
    Alzheimers Res Ther; 2017 Apr; 9(1):34. PubMed ID: 28446209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Analysis of adverse reactions and pharmacovigilance research to parenterally administered shuxuening].
    Yang W; Xiang YY; Xie YM; Shen H
    Zhongguo Zhong Yao Za Zhi; 2013 Sep; 38(18):3013-8. PubMed ID: 24471322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prevalence of dementia and Alzheimer's disease among subjects aged 75 years or over: updated results of the PAQUID cohort].
    Ramaroson H; Helmer C; Barberger-Gateau P; Letenneur L; Dartigues JF;
    Rev Neurol (Paris); 2003 Apr; 159(4):405-11. PubMed ID: 12773869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. No differences between men and women in adverse drug reactions related to psychotropic drugs: a survey from France, Italy and Spain.
    D'Incau P; Lapeyre-Mestre M; Carvajal A; Donati M; Salado I; Rodriguez L; Sáinz M; Escudero A; Conforti A
    Fundam Clin Pharmacol; 2014 Jun; 28(3):342-8. PubMed ID: 23617454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paradoxical adverse drug reactions: descriptive analysis of French reports.
    Hakimi Y; Petitpain N; Pinzani V; Montastruc JL; Bagheri H
    Eur J Clin Pharmacol; 2020 Aug; 76(8):1169-1174. PubMed ID: 32418024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparative study of adverse drug reactions during two heat waves that occurred in France in 2003 and 2006.
    Sommet A; Durrieu G; Lapeyre-Mestre M; Montastruc JL;
    Pharmacoepidemiol Drug Saf; 2012 Mar; 21(3):285-8. PubMed ID: 22162094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The need for a consensus in the use of assessment tools for Alzheimer's disease: the Feasibility Study (assessment tools for dementia in Alzheimer Centres across Europe), a European Alzheimer's Disease Consortium's (EADC) survey.
    Paulino Ramirez Diaz S; Gil Gregório P; Manuel Ribera Casado J; Reynish E; Jean Ousset P; Vellas B; Salmon E
    Int J Geriatr Psychiatry; 2005 Aug; 20(8):744-8. PubMed ID: 16035121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Adverse drug reactions in pediatrics: Experience of a regional pharmacovigilance center].
    Saint-Martin C; Kanagaratnam L; de Boissieu P; Azzouz B; Abou Taam M; Trenque T
    Therapie; 2016 Oct; 71(5):467-473. PubMed ID: 27203165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Severe adverse effects of bromocriptine in lactation inhibition: a pharmacovigilance survey.
    Bernard N; Jantzem H; Becker M; Pecriaux C; Bénard-Laribière A; Montastruc JL; Descotes J; Vial T;
    BJOG; 2015 Aug; 122(9):1244-51. PubMed ID: 25761676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.